Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (8): 886-893.doi: 10.3736/jcim20120809

Previous Articles     Next Articles

Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance

Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu()   

  1. Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Received:2011-12-13 Accepted:2011-12-25 Online:2012-08-20 Published:2018-08-15
  • Contact: Zhu De-zeng E-mail:zdzzyx@163.com

Objective: To observe the effects of ursolic acid (UA) on insulin resistance and cell differentiation in 3T3-L1 adipocytes and to explore the mechanisms.

Methods: 3T3-L1 adipocytes were cultured in Dulbecco‘s modified Eagle‘s medium (DMEM) supplemented with glucose (25 mmol/L) and insulin (10 -6 mol/L) to induce insulin resistance. After culture, glucose consumption of the adipocytes was detected by glucose oxidase method and glucose uptake was detected by using tritium-marked glucose. Drug concentration for following test was determined through detecting the effects of different concentrations of UA on the activity of 3T3-L1 adipocytes with insulin resistance by methyl thiazolyl tetrazolium (MTT) staining. 3T3-L1 adipocytes with insulin resistance were cultured with DMEM, rosiglitazone, and low- and high-dose UA, and then, glucose uptake and differentiation of 3T3-L1 adipocytes were detected. Finally, real-time fluorescence quantitative polymerase chain reaction and Western blot methods were used to detect the effects of UA on expressions of adipocyte lipid binding protein (aP2), c-Cbl-associated protein (CAP) and matrix metalloproteinase-1 (MMP-1) in 3T3-L1 cells with insulin resistance.

Results: After dealing with high glucose/hyperinsulin for 24 h, insulin resistance was induced successfully in the 3T3-L1 adipocytes. The concentrations of UA were defined to be 4 to 20 μmol/L. Compared with the model group, the glucose uptake was significantly increased in the rosiglitazone group and groups treated with low- and high-dose UA (P<0.01). The differentiation levels of 3T3-L1 adipocytes in the UA groups were lower than those in the control group and the rosiglitazone group. Effects of UA on the expressions of aP2 and MMP-1 were not obvious, but UA could up-regulate expression of CAP both in mRNA and protein levels (P<0.01).

Conclusion: Low- and high-dose UA can improve the glycometabolism and differentiation of 3T3-L1 adipocytes with insulin resistance by up-regulating the expression of CAP.

Key words: ursolic acid, diabetes mellitus, adipocytes, insulin resistance, cell differentiation, matrix metalloproteinase 1, proto-oncogene proteins c-cbl, 3T3-L1 cells

Figure 1

Effects of high glucose/hyperinsulin on glucose consumption in 3T3-L1 cellsData are expressed as $\bar{x}$±s, n=3. **P<0.01, vs normal cells; △△P<0.01, vs high glucose-treated 3T3-L1 cells. "

Figure 2

Effects of high glucose/hyperinsulin on glucose uptake in 3T3-L1 cells Data are expressed as $\bar{x}$±s, n=3. **P<0.01, vs normal cells; △△P<0.01, vs high glucose-treated 3T3-L1 cells."

Table 1

Effects of different concentrations of ursolic acid on viability of 3T3-L1 adipocytes ($\bar{x}$±s)"

Group n Survival rate of 3T3-L1 adipocytes
12 h 24 h 36 h 48 h
0 3 1 1 1 1
0.02 μmol/L ursolic acid 3 0.91±0.02 0.94±0.03 0.96±0.01 0.97±0.02
0.04 μmol/L ursolic acid 3 0.94±0.01 0.97±0.04 0.96±0.03 0.98±0.01
0.2 μmol/L ursolic acid 3 0.91±0.05 0.91±0.03 0.95±0.01 0.99±0.02
0.4 μmol/L ursolic acid 3 0.96±0.04 0.89±0.07 0.94±0.05 0.10±0.02
2 μmol/L ursolic acid 3 0.86±0.04 0.88±0.09 0.97±0.04 0.99±0.06
4 μmol/L ursolic acid 3 0.96±0.03 0.96±0.05 0.98±0.07 0.98±0.04
20 μmol/L ursolic acid 3 1.13±0.04 1.06±0.03 1.15±0.07 1.13±0.06
40 μmol/L ursolic acid 3 0.22±0.06 0.33±0.01 0.32±0.04 0.57±0.03
200 μmol/L ursolic acid 3 0.23±0.01 0.21±0.04 0.17±0.02 0.35±0.03

Table 2

Effects of ursolic acid on glucose uptake in 3T3-L1 adipocytes ($\bar{x}$±s)"

Group Concentration n Glucose uptake (d/min)
Normal 3 9 876±162▲▲
IR 3 7 288±128▲▲
Rosiglitazone 5 μmol/L 3 9 090±120**
Low-dose ursolic acid 10 μmol/L 3 8 111±875**▲▲
High-dose ursolic acid 20 μmol/L 3 8 497±117**▲▲

Table 3

Effects of ursolic acid on differentiation of 3T3-L1 adipocytes ($\bar{x}$±s)"

Group Concentration n Optical density570
Normal 12 0.54±0.03▲▲
IR 12 0.63±0.12
Rosiglitazone 5 μmol/L 12 0.77±0.04**
Low-dose ursolic acid 10 μmol/L 12 0.33±0.04**▲▲
High-dose ursolic acid 20 μmol/L 12 0.21±0.07**▲▲

Figure 3

Effects of ursolic acid on relative expressions of aP2, CAP and MMP-1 mRNAs in 3T3-L1 cells Data are expressed as mean ± standard deviation, n=3. **P<0.01, vs normal group; P<0.05, vs IR group. IR: insulin resistance; aP2: adipocyte lipid-binding protein; CAP: c-Cbl-associated protein; MMP-1: matrix metalloproteinase-1."

Figure 4

Effects of ursolic acid on expressions of aP2, CAP and MMP-1 proteins in 3T3-L1 cellsData are expressed as mean ± standard deviation, n=3. **P<0.01, vs normal group; **P<0.01, vs IR group. IR: insulin resistance; aP2: adipocyte lipid-binding protein; CAP: c-Cbl-associated protein; MMP-1: matrix metalloproteinase-1."

[1] Niikawa M, Hayashi H, Sato T, Nagase H, Kito H . Isolation of substances from glossy privet(Ligustrum lucidum Ait.) inhibiting the mutagenicity of benzo[a]pyrene in bacteria[J]. Mutat Res, 1993,319(1):1-9
doi: 10.1016/0165-1218(93)90025-9
[2] Young HS, Chung HY, Lee CK, Park KY, Yokozawa T, Oura H . Ursolic acid inhibits aflatoxin B1-induced mutagenicity in a Salmonella assay system[J]. Biol Pharm Bull, 1994,17(7):990-992
doi: 10.1248/bpb.17.990 pmid: 8000393
[3] Giannini S, Serio M, Galli A . Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity[J]. J Endocrinol Invest, 2004,27(10):982-991
doi: 10.1007/BF03347546 pmid: 15762051
[4] Staels B . PPARgamma and atherosclerosis[J]. Curr Med Res Opin, 2005,21(Suppl 1):S13-S20
[5] Zhang J, Wu SY, Wang L, Wang GL, Zhu DZ . Effects of ursolic acid on fat metabolism in high-fat-fed induced insulin resistance rats[J]. Zhonghua Zhong Yi Yao Xue Kan, 2010,28(5):975-978
张杰, 吴淑艳, 王琳, 王冠梁, 朱德增 . 熊果酸对高脂饮食诱导胰岛素抵抗大鼠脂质代谢的影响[J]. 中华中医药学刊, 2010,28(5):975-978
[6] Sowers JR, Frohlich ED . Insulin and insulin resistance: impact on blood pressure and cardiovascular disease[J]. Med Clin North Am, 2004,88(1):63-82
doi: 10.1016/S0025-7125(03)00128-7
[7] Feng Q, Hu YY . Syndromes and pathological mechanism of insulin resistance in traditional Chinese medicine[J]. J Chin Integr Med, 2005,3(1):63-65
冯琴, 胡义扬 . 胰岛素抵抗的中医病机证候特点[J]. 中西医结合学报, 2005,3(1):63-65
[8] Wang SH, Wang WJ . Pathogenesis of insulin resistance and prevention and treatment strategy of integrated traditional Chinese and Western medicine[J]. J Chin Integr Med, 2004,2(1):14-16
doi: 10.3736/jcim20040106
王树海, 王文健 . 胰岛素抵抗的发病机制及中西医结合防治策略[J]. 中西医结合学报, 2004,2(1):14-16
doi: 10.3736/jcim20040106
[9] Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK . Ursolic acid enhances the cellular immune system and pancreatic β-cell function in streptozotocin-induced diabetic mice fed a high-fat diet[J]. Int Immunopharmacol, 2009,9(1):113-119
doi: 10.1016/j.intimp.2008.10.013
[10] Jung SH, Ha YJ, Shim EK, Choi SY, Jin JL, Yun-Choi HS, Lee JR . Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator[J]. Biochem J, 2007,403(2):243-250
doi: 10.1042/BJ20061123
[11] Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR . A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes[J]. Mol Cell Biol, 1998,18(2):872-879
doi: 10.1128/MCB.18.2.872
[12] Reese-Wagoner A, Thompson J, Banaszak L . Structural properties of the adipocyte lipid binding protein[J]. Biochim Biophys Acta, 1999,1441(2-3):106-116
doi: 10.1016/S1388-1981(99)00154-7 pmid: 10570239
[13] Redlich M, Roos H, Reichenberg E, Zaks B, Grosskop A, Bar Kana I, Pitaru S, Palmon A . The effect of centrifugal force on mRNA levels of collagenase, collagen type-Ⅰ, tissue inhibitors of metalloproteinases and beta-actin in cultured human periodontal ligament fibroblasts[J]. J Periodontal Res, 2004,39(1):27-32
doi: 10.1111/j.1600-0765.2004.00700.x
[14] Lai MY, Leung HW, Yang WH, Chen WH, Lee HZ . Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis[J]. Anticancer Res, 2007,27(1A):145-153
[15] Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, Saltiel AR . Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10[J]. Nature, 2001,410(6831):944-948
doi: 10.1038/35073608 pmid: 11309621
[1] Mohadeseh Ostovar, Abolfazl Akbari, Mohammad Hossein Anbardar, Aida Iraji, Mohsen Salmanpour, Salar Hafez Ghoran, Mojtaba Heydari, Mesbah Shams. Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy. Journal of Integrative Medicine, 2020, 18(1): 59-67.
[2] Supakanya Kumkarnjana, Rutt Suttisri, Ubonthip Nimmannit, Apirada Sucontphunt, Mattaka Khongkow, Thongchai Koobkokkruad, Nontima Vardhanabhuti. Flavonoids kaempferide and 4,2′-dihydroxy-4′,5′,6′-trimethoxychalcone inhibit mitotic clonal expansion and induce apoptosis during the early phase of adipogenesis in 3T3-L1 cells. Journal of Integrative Medicine, 2019, 17(4): 288-295.
[3] Eric Wei Chiang Chan, Chu Yong Soon, Joash Ban Lee Tan, Siu Kuin Wong, Yew Woh Hui. Ursolic acid: An overview on its cytotoxic activities against breast and colorectal cancer cells. Journal of Integrative Medicine, 2019, 17(3): 155-160.
[4] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[5] Syed Nasir Abbas Bukhari, Fahad Hussain, Hnin Ei Thu, Zahid Hussain. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. Journal of Integrative Medicine, 2019, 17(1): 38-45.
[6] Supakanya Kumkarnjana, Rutt Suttisri, Ubonthip Nimmannit, Thongchai Koobkokkruad, Chutichot Pattamadilok, Nontima Vardhanabhuti . Anti-adipogenic effect of flavonoids from Chromolaena odorata leaves in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2018, 16(6): 427-434.
[7] Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334.
[8] Olakunle Bamikole Afolabi, Omotade Ibidun Oloyede, Shadrack Oludare Agunbiade. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe2+-induced pancreatic oxidative stress. Journal of Integrative Medicine, 2018, 16(3): 192-198.
[9] Chun-song Hu, Tengiz Tkebuchava. SEEDi1.0-3.0 strategies for major noncommunicable diseases in China. Journal of Integrative Medicine, 2017, 15(4): 265-269.
[10] Uduak Akpan Okon, Idorenyin Udo Umoren. Comparison of antioxidant activity of insulin, Ocimum gratissimum L., and Vernonia amygdalina L. in type 1 diabetic rat model. Journal of Integrative Medicine, 2017, 15(4): 302-309.
[11] Nazli Samadi, Hassan Mozaffari-Khosravi, Masoud Rahmanian, Mohsen Askarishahi. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: A randomized, double-blind clinical trial. Journal of Integrative Medicine, 2017, 15(2): 124-134.
[12] Yee Chi Peggy Wong. Need of integrated dietary therapy for persons with diabetes mellitus and “unhealthy” body constitution presentations. Journal of Integrative Medicine, 2016, 14(4): 255-268.
[13] Ausanee Wanchai, Duangjai Phrompayak. Use of complementary and alternative medicine among Thai patients with type 2 diabetes mellitus. Journal of Integrative Medicine, 2016, 14(4): 297-305.
[14] Sulaiman Al-Eidi, SalwaTayel, Fatima Al-Slail, Naseem Akhtar Qureshi, Imen Sohaibani, Mohamed Khalil, Abdullah Mohammad Al-Bedah. Knowledge, attitude and practice of patients with type 2 diabetes mellitus towards complementary and alternative medicine. Journal of Integrative Medicine, 2016, 14(3): 187-196.
[15] Mohammad Hashem Hashempur, Mojtaba Heydari, Seyed Hamdollah Mosavat, Seyyed Taghi Heydari, Mesbah Shams. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. Journal of Integrative Medicine, 2015, 13(5): 319-325.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[5] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[6] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[7] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[8] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[9] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022